Family Variant

Family follow-up testing

Testing for patients whose relatives have a known genetic variant. We offer family follow-up testing for patients with a relative who was tested at Genomed and was found to have a pathogenic/likely pathogenic variant or a variant of uncertain significance (VUS).

Family variant testing

We offer family variant testing for all blood relatives of patients who undergo diagnostic or proactive testing at Genomed and are found to have a pathogenic or likely pathogenic variant. Our family variant testing reports on the variant(s) that was identified in the original family member, as well as any other pathogenic variant(s) found in the full gene.

Genetic insights are a family affair

For patients who undergo diagnostic or proactive testing at Genomed and are found to have a pathogenic or likely pathogenic variant, their blood relatives can have up to a 50% risk of having the same variant.

– Identifying the presence of a variant—sometimes even before symptoms occur—can enable preventive medical management

– Identifying the absence of a variant can also have significant implications for relatives

Recent evidence shows that only a small percentage of relatives pursue follow-up testing.

Reasons relatives do not pursue testing include lack of knowledge about the potential disease risk, family communication barriers, lack of access to genetics services, and cost of testing.

As part of our commitment to lowering barriers to genetic testing, we offer testing to blood relatives of probands who were found to have a pathogenic or likely pathogenic variant.

Eligibility & requirements

– Blood relatives of a patient who was tested at Genomed

– A pathogenic or likely pathogenic variant was found

– The timeline to place an order has been temporarily extended to 150 days (from 90 days). In addition samples must be received within 160 days (up from 100 days) of the original patient’s test report.

– Available for diagnostic and proactive panel and single-gene testing only; not available for exome or reproductive health testing